Formycon launches first ranibizumab biosimilar in pre-filled syringe By Investing.com - Stock Watch Index

Formycon launches first ranibizumab biosimilar in pre-filled syringe By Investing.com

October 21, 2025

Formycon launches first ranibizumab biosimilar in pre-filled syringe

Search

RECENT PRESS RELEASES

USD/JPY: Bullish Momentum Returns With Focus on 152.50 Resistance

SWI Editorial Staff2025-10-21T01:51:34-07:00October 21, 2025|

BMO Capital initiates Solstice Advanced Materials stock with Outperform rating By Investin

SWI Editorial Staff2025-10-21T01:51:14-07:00October 21, 2025|

Berenberg initiates secunet Security Networks stock with Buy rating By Investing.com

SWI Editorial Staff2025-10-21T01:50:51-07:00October 21, 2025|

Zoomd Technologies stock initiated at Outperform by ATB Capital Markets By Investing.com

SWI Editorial Staff2025-10-21T01:50:32-07:00October 21, 2025|

Assa Abloy reports solid Q3 with Nordic growth acceleration By Investing.com

SWI Editorial Staff2025-10-21T01:50:08-07:00October 21, 2025|

Bernstein initiates coverage on Interparfums stock with Outperform rating By Investing.com

SWI Editorial Staff2025-10-21T01:49:44-07:00October 21, 2025|

Related Post